Expert Perspectives

Use the tool below to view all available Global Neurology Academy Series

Treatment of Progressive MS: Why, Who, When, How
Treatment of Progressive MS: Why, Who, When, How
Resources
Treatment of Progressive MS: Why, Who, When, How
- Giancarlo Comi, MD
More Than “Women’s Issues": Women’s Reproductive and Gynaecological Health and Work
More Than “Women’s Issues": Women’s Reproductive and Gynaecological Health and Work
Resources
More Than “Women’s Issues": Women’s Reproductive and Gynaecological Health and Work
Now Approved in Europe: First Oral Short-Course Treatment for Highly Active Relapsing MS
Now Approved in Europe: First Oral Short-Course Treatment for Highly Active Relapsing MS
Resources
Now Approved in Europe: First Oral Short-Course Treatment for Highly Active Relapsing MS
Cladribine Receives Positive CHMP Opinion for Relapsing MS Treatment
Cladribine Receives Positive CHMP Opinion for Relapsing MS Treatment
Resources
Cladribine Receives Positive CHMP Opinion for Relapsing MS Treatment
The Diagnostic Challenges of Spinal Cord Lesions in MS
The Diagnostic Challenges of Spinal Cord Lesions in MS
CME/CE
The Diagnostic Challenges of Spinal Cord Lesions in MS
- Jiwon Oh, MD, PhD
Reducing the Burden of MS Treatment
Reducing the Burden of MS Treatment
Resources
Reducing the Burden of MS Treatment
Therapeutic Mechanism of Action (MOAs) in MS: Targeting T- and B-cells to Reset the Immune System
Therapeutic Mechanism of Action (MOAs) in MS: Targeting T- and B-cells to Reset the Immune System
Resources
Therapeutic Mechanism of Action (MOAs) in MS: Targeting T- and B-cells to Reset the Immune System
Immunologic Effects on Metabolic Syndrome and MS
Immunologic Effects on Metabolic Syndrome and MS
Interviews
Immunologic Effects on Metabolic Syndrome and MS
Establishing Partnerships to Optimize Patient Outcomes
Establishing Partnerships to Optimize Patient Outcomes
Interviews
Establishing Partnerships to Optimize Patient Outcomes
Highlights from the MAGNIMS Consensus Guidelines
Highlights from the MAGNIMS Consensus Guidelines
Interviews
Highlights from the MAGNIMS Consensus Guidelines
Optimizing MS Treatment Options
Optimizing MS Treatment Options
Interviews
Optimizing MS Treatment Options
The Value of Biomarkers in MS Patients
The Value of Biomarkers in MS Patients
Interviews
The Value of Biomarkers in MS Patients
Emerging MRI Techniques in MS Patients
Emerging MRI Techniques in MS Patients
CME/CE
Emerging MRI Techniques in MS Patients
Current Landscape of MS Diagnosis/Prognosis
Current Landscape of MS Diagnosis/Prognosis
CME/CE
Current Landscape of MS Diagnosis/Prognosis
Early Diagnosis/Long-Term Prognosis of MS - Dr. Jiwon Oh
Early Diagnosis/Long-Term Prognosis of MS - Dr. Jiwon Oh
CME/CE
Early Diagnosis/Long-Term Prognosis of MS - Dr. Jiwon Oh
Determining an MS Patient's Long-Term Prognosis
Determining an MS Patient's Long-Term Prognosis
CME/CE
Determining an MS Patient's Long-Term Prognosis

Expert Perspectives

Popular

NEED HELP?

Contact us

NEED HELP?

Contact us

Expert Perspectives

Popular

Title

Share on ReachMD